EP2793813A1 — Cosmetic composition and uses thereof in the treatment of lipodystrophies
Assigned to Individual · Expires 2014-10-29 · 12y expired
What this patent protects
The present invention relates to a cosmetic composition based on iron ion (Fe 2+ and/or Fe 3+ ) chelating agents and the use thereof for the non-surgical treatment of lipodystrophies and of so-called "cellulite". In particular, the composition of the present inve…
USPTO Abstract
The present invention relates to a cosmetic composition based on iron ion (Fe 2+ and/or Fe 3+ ) chelating agents and the use thereof for the non-surgical treatment of lipodystrophies and of so-called "cellulite". In particular, the composition of the present invention comprises at least one Fe 2+ and/or Fe 3+ ion chelating agent, at least one osmotic diuretic, at least one amino acid and at least one vitamin. Said composition makes it possible to considerably improve the aesthetic appearance of areas of the body, in particular the lower limbs, affected by an accumulation and structural alteration of adipose tissue. In fact, the degree of satisfaction of the subjects who underwent the cosmetic treatment of the present invention is high.
Drugs covered by this patent
- Kybella (DEOXYCHOLIC ACID) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.